US Kidney Research
Roseville, US · Founded 2015 · Delaware corporation
Founders & leadership
RL
Roland LudlowExecutive
Reported raises · per SEC filings
Form D private placements$4.9M disclosed across 10 rounds · 2015–2026
▶$475KraisedAug 2026 · 2 investors · Other Health CareRule 506(b)
▶$475KraisedAug 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roland LudlowExecutive Officer
- Offering amount
- $475K
- Amount sold
- $475K
- Minimum investment
- $7.5K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$475KraisedJan 2025 · Other Health CareRule 506(b)
▶$475KraisedJan 2025 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roland LudlowExecutive Officer
- Offering amount
- $475K
- Amount sold
- $475K
- Minimum investment
- $475K
- Proceeds to insiders
- $125K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedJan 2025 · Other Health CareRule 506(b)
▶$1.5MraisedJan 2025 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roland LudlowExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $1.5M
- Proceeds to insiders
- $70K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$320KraisedOct 2020 · Other Health CareRule 506(b)
▶$320KraisedOct 2020 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roland LudlowExecutive Officer
- Offering amount
- $320K
- Amount sold
- $320K
- Minimum investment
- $320K
- Proceeds to insiders
- $70K
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$500KraisedFeb 2020 · Other Health CareRule 506(b)
▶$500KraisedFeb 2020 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roland LudlowExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- Minimum investment
- $250K
- Proceeds to insiders
- $70K
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$600KraisedOct 2018 · 1 investors · Other Health CareRule 506(b)
▶$600KraisedOct 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roland LudlowExecutive Officer
- Offering amount
- $600K
- Amount sold
- $600K
- Minimum investment
- $600K
- Proceeds to insiders
- $70K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$373.9KraisedOct 2017 · 1 investors · Other Health CareRule 506(b)
▶$373.9KraisedOct 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roland LudlowExecutive Officer
- Offering amount
- $373.9K
- Amount sold
- $373.9K
- Minimum investment
- $373.9K
- Proceeds to insiders
- $70K
- First sale
- Aug 2017
- Incorporated
- Corporation, California, 2015
- Federal exemptions
- 06b
▶$187KraisedSep 2016 · 1 investors · Other Health CareRule 506(b)
▶$187KraisedSep 2016 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- ROLAND LUDLOWExecutive Officer
- Offering amount
- $187K
- Amount sold
- $187K
- Minimum investment
- $187K
- Proceeds to insiders
- $70K
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has US Kidney Research raised?
- US Kidney Research has disclosed $4.9M raised across 10 rounds.
- Where is US Kidney Research headquartered?
- US Kidney Research is headquartered in Roseville, US.